🇺🇸 FDA
Patent

US 9873722

Wnt compositions and therapeutic uses of such compositions

granted A61KA61K38/00A61P

Quick answer

US patent 9873722 (Wnt compositions and therapeutic uses of such compositions) held by Fate Therapeutics, Inc. expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Fate Therapeutics, Inc.
Grant date
Tue Jan 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61P, A61P21/00